Jose Gil Munguia-Lopez

Dr. Jose Gil Munguia-Lopez

Bioengineering, McGill University, Montréal, Quebec, Canada
orcid
Research Associate

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2019 in Applied Physics Reviews
Verified
Journal Article
Open access
PDF file
TJTao Jiang
Tao Jiang
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
SFSalvador Flores-Torres
Salvador Flores-Torres
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
JKJoseph M. Kinsella
Joseph M. Kinsella
Bioprinting has attracted increasing attention in the tissue engineering field and has been touted to potentially become the leading technology to fabricate, and regenerate, tissues and organs. Bioprinting is derived from well-known additive manufacturing (AM) technology, which features layered deposition of materials into complex three-dimensional geometries that are difficult to fabricate using conventional manufacturing methods. Unlike the conventional thermoplastics used in desktop, AM bioprinting uses cell-laden hydrogel materials, also known as bioinks, to construct complex living biological model systems. Inkjet, stereolithography, laser-induced forward transfer, and extrusion are the four main methods in bioprinting, with extrusion being the most commonly used. In extrusion-based bioprinting, soft materials are loaded into the cartridges and extruded from the nozzle via pneumatic or mechanical actuation. Multiple materials can be printed into the same structure resulting in heterogeneous models. In this focused review, we first review the different methods to describe the physical mechanisms of the extrusion process, followed by the commonly employed bioprintable soft materials with their mechanical and biochemical properties and finally reviewing the up-to-date heterogeneous in vitro models afforded via bioprinting.

22 November 2021 in Molecules
Verified
Journal Article
Open access
PDF file
DWDavid T. Wu
David T. Wu
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
YCYe Won Cho
Ye Won Cho
XMXiaolu Ma
Xiaolu Ma
VSVivian Song
Vivian Song
STSimon D. Tran
Simon D. Tran
Dental, oral, and craniofacial (DOC) regenerative medicine aims to repair or regenerate DOC tissues including teeth, dental pulp, periodontal tissues, salivary gland, temporomandibular joint (TMJ), hard (bone, cartilage), and soft (muscle, nerve, skin) tissues of the craniofacial complex. Polymeric materials have a broad range of applications in biomedical engineering and regenerative medicine functioning as tissue engineering scaffolds, carriers for cell-based therapies, and biomedical devices for delivery of drugs and biologics. The focus of this review is to discuss the properties and clinical indications of polymeric scaffold materials and extracellular matrix technologies for DOC regenerative medicine. More specifically, this review outlines the key properties, advantages and drawbacks of natural polymers including alginate, cellulose, chitosan, silk, collagen, gelatin, fibrin, laminin, decellularized extracellular matrix, and hyaluronic acid, as well as synthetic polymers including polylactic acid (PLA), polyglycolic acid (PGA), polycaprolactone (PCL), poly (ethylene glycol) (PEG), and Zwitterionic polymers. This review highlights key clinical applications of polymeric scaffolding materials to repair and/or regenerate various DOC tissues. Particularly, polymeric materials used in clinical procedures are discussed including alveolar ridge preservation, vertical and horizontal ridge augmentation, maxillary sinus augmentation, TMJ reconstruction, periodontal regeneration, periodontal/peri-implant plastic surgery, regenerative endodontics. In addition, polymeric scaffolds application in whole tooth and salivary gland regeneration are discussed.

4 July 2017 in Scientific Reports
Verified
Journal Article
Open access
PDF file
TJTao Jiang
Tao Jiang
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
SFSalvador Flores-Torres
Salvador Flores-Torres
JGJoel Grant
Joel Grant
SVSanahan Vijayakumar
Sanahan Vijayakumar
JJoseph Kinsella
Joseph Kinsella
Human tumour progression is a dynamic process involving diverse biological and biochemical events such as genetic mutation and selection in addition to physical, chemical, and mechanical events occurring between cells and the tumour microenvironment. Using 3D bioprinting we have developed a method to embed MDA-MB-231 triple negative breast cancer cells, and IMR-90 fibroblast cells, within a cross-linked alginate/gelatin matrix at specific initial locations relative to each other. After 7 days of co-culture the MDA-MB-231 cells begin to form multicellular tumour spheroids (MCTS) that increase in size and frequency over time. After ~15 days the IMR-90 stromal fibroblast cells migrate through a non-cellularized region of the hydrogel matrix and infiltrate the MDA-MB-231 spheroids creating mixed MDA-MB-231/IMR-90 MCTS. This study provides a proof-of-concept that biomimetic in vitro tissue co-culture models bioprinted with both breast cancer cells and fibroblasts will result in MCTS that can be maintained for durations of several weeks.

14 August 2020 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
MTMandana Tavakolian
Mandana Tavakolian
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
AVAmin Valiei
Amin Valiei
SIShahidul Islam
Shahidul Islam
JKJoseph M. Kinsella
Joseph M. Kinsella
TVTheo Van de Ven
Theo Van de Ven

31 December 2019 in Biofabrication
Verified
Journal Article
Closed access
TJTao Jiang
Tao Jiang
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
KGKevin Gu
Kevin Gu
MBMaeva M Bavoux
Maeva M Bavoux
SFSalvador Flores-Torres
Salvador Flores-Torres
JJoseph Kinsella
Joseph Kinsella
Tunable bioprinting materials are capable of creating a broad spectrum of physiological mimicking 3D models enabling in vitro studies that more accurately resemble in vivo conditions. Tailoring the material properties of the bioink such that it achieves both bioprintability and biomimicry remains a key challenge. Here we report the development of engineered composite hydrogels consisting of gelatin and alginate components. The composite gels are demonstrated as a cell-laden bioink to build 3D bioprinted in vitro breast tumor models. The initial mechanical characteristics of each composite hydrogel are correlated to cell proliferation rates and cell spheroid morphology spanning month long culture conditions. MDA-MB-231 breast cancer cells show gel formulation-dependency on the rates and frequency of self-assembly into multicellular tumor spheroids (MCTS). Hydrogel compositions comprised of decreasing alginate concentrations, and increasing gelatin concentrations, result in gels that are mechanically soft and contain a greater number of cell-adhesion moieties driving the development of large MCTS; conversely gels containing increasing alginate, and decreasing gelatin concentrations are mechanically stiffer, with fewer cell-adhesion moieties present in the composite gels yielding smaller and less viable MCTS. These composite hydrogels can be used in the biofabrication of tunable in vitro systems that mimic both the mechanical and biochemical properties of the native tumor stroma.

10 March 2021 in Biofabrication
Verified
Journal Article
Closed access
PDF file
SFSalvador Flores-Torres
Salvador Flores-Torres
OPOmar Peza-Chavez
Omar Peza-Chavez
HKHellen Kuasne
Hellen Kuasne
Jose Gil Munguia-LopezJose Gil Munguia-Lopez
Jose Gil Munguia-Lopez
JKJacqueline Kort-Mascort
Jacqueline Kort-Mascort
JJoseph Kinsella
Joseph Kinsella
Hydrogels consisting of controlled fractions of alginate, gelatin, and Matrigel enable the development of patient-derived bioprinted tissue models that support cancer spheroid growth and expansion. These engineered models can be dissociated to be then reintroduced to new hydrogel solutions and subsequently reprinted to generate multigenerational models. The process of harvesting cells from 3D bioprinted models is possible by chelating the ions that crosslink alginate, causing the gel to weaken. Inclusion of the gelatin and Matrigel fractions to the hydrogel increases the bioactivity by providing cell-matrix binding sites and promoting cross-talk between cancer cells and their microenvironment. Here we show that immortalized triple-negative breast cancer cells (MDA-MB-231) and patient-derived gastric adenocarcinoma cells can be reprinted for at least three 21 d culture cycles following bioprinting in the alginate/gelatin/Matrigel hydrogels. Our drug testing results suggest that our 3D bioprinted model can also be used to recapitulate in vivo patient drug response. Furthermore, our results show that iterative bioprinting techniques coupled with alginate biomaterials can be used to maintain and expand patient-derived cancer spheroid cultures for extended periods without compromising cell viability, altering division rates, or disrupting cancer spheroid formation.